General Hospital Psychiatry
Volume 32, Issue 5 , Pages 559.e11-559.e13 , September 2010

A case of schizophrenia with dysphagia successfully treated by a multidimensional approach

Received 5 December 2009 ,Accepted 26 January 2010.

References 

  1. Regan J, Sowman R, Walsh I. Prevalence of dysphagia in acute and community mental health settings. Dysphagia. 2006;95–101
  2. Rudolph JL, Gardner KF, Gramigna GD, McGlinchey RE. Antipsychotics and oropharyngeal dysphagia in hospitalized older patients. J Clin Psychopharmacol. 2008;28:532–535
  3. Knol W, van Marum RJ, Jansen PA, Souverein PC, Schobben AF, Egberts AC. Antipsychotic drug use and risk of pneumonia in elderly people. J Am Geriatr Soc. 2008;56:661–666
  4. Keshavan MS, Tandon R, Boutros NN, Nasrallah HA. Schizophrenia, “just the facts”: What we know in 2008 Part 3: Neurobiology. Schizophr Res. 2008;106:89–107
  5. Picard H, Amado I, Mouchet-Mages S, Olie' JP, Krebs MO. The role of the cerebellum in schizophrenia: an update of clinical, cognitive, and functional evidences. Schizophr Bull. 2008;34(1):155–172
  6. Bhidayasiri R. Dystonia: genetics and treatment update. Neurologist. 2006;12:74–85
  7. Fernandez HH, Friedman JH. Classification and treatment of tardive syndromes. Neurologist. 2003;9:16–27
  8. Bazemore PH, Tonkonogy J, Ananth R. Dysphagia in psychiatric patients: clinical and videofluoroscopic study. Dysphagia. 1991;6:2–5
  9. Stones M, Kennie DC, Fulton JD. Dystonic dysphagia associated with fluspirilene. BMJ. 1990;301(6753):668–669
  10. Nair S, Saeed O, Shahab H, Sedky K, Garver D, Lippmann S. Sudden dysphagia with uvular enlargement following the initiation of risperidone which responded to benztropine: was this an extrapyramidal side effect?. Gen Hosp Psychiatry. 2001;23:230–234
  11. Aino I, Saigusa H, Nakamura T, Matsuoka C, Komachi T, Kokawa T. Progressive dysphagia with peculiar laryngeal movement induced by tardive dystonia. Nippon Jibiinkoka Gakkai Kaiho. 2006;109(11):785–788
  12. Duggal HS, Mendhekar DN. Risperidone-induced tardive pharyngeal dystonia presenting with persistent dysphagia: a case report. Prim Care Companion. J Clin Psychiatry. 2008;10(2):161–162
  13. Bakheit AMO. Management of neurogenic dysphagia. Postgrad Med J. 2001;77:694–699
  14. Gates J, Hartnell GG, Gramigna GD. Videofluoroscopy and swallowing studies for neurologic disease: a primer. Radiographics. 2006;26(1):e22
  15. Dziewas R, Warnecke T, Schnabel M, Ritter M, Nabavi DG, Schilling M, et al. Neuroleptic-induced dysphagia: case report and literature review. Dysphagia. 2007;22:63–67
  16. Varghese ST, Balhara YPS, George SA, Sagar R. Risperidone and dysphagia. J Postgrad Med. 2006;52(4):327–328
  17. Kohen I, Lester P. Quetiapine-associated dysphagia. World J Biol Psychiatry. 2008;10:1–3
  18. Hayashi T, Nishikawa T, Koga I, Uchida Y, Yamawaki S. Life-threatening dysphagia following prolonged neuroleptic therapy. Clin Neuropharmacol. 1997;20(1):77–81
  19. Lister R. Oropharyngeal dysphagia and nutritional management. Curr Opin Gastroenterol. 2006;22:341–346

PII: S0163-8343(10)00013-7

doi: 10.1016/j.genhosppsych.2010.01.012

General Hospital Psychiatry
Volume 32, Issue 5 , Pages 559.e11-559.e13 , September 2010

Article Tools